Expanded T cell clones with lymphoma driver somatic mutations accumulate in refractory celiac disease
Details
Publication Year 2025-05-14,Volume 17,Issue #798,Page eadp6812
Journal Title
Science Translational Medicine
Abstract
Intestinal inflammation continues in a subset of patients with celiac disease despite a gluten-free diet. Here, by applying multi-omic single-cell analysis to duodenal biopsies, we found that low-grade malignancies with lymphoma driver mutations in patients with refractory celiac disease type 2 (RCD2) are comprised by surface CD3-negative (sCD3(-)) lymphocytes stalled at an innate lymphoid cell (ILC)-progenitor T cell stage undergoing extensive TRA, TRB, and TRD TCR recombination. In people with refractory celiac disease type 1 (RCD1), a disease currently lacking explanation, we identified sCD3(+) T cells with lymphoma driver mutations in 6 of 10 individuals with RCD1 and in one of the patients with active, recently diagnosed celiac disease. Furthermore, the mutant T cells formed large TCRαβ clones and displayed inflammatory and cytotoxic molecular profiles. Thus, accumulation of lymphoma driver-mutated T cells and sCD3(-) progenitors may contribute to chronic, nonresponsive celiac disease.
Publisher
AAAS
Keywords
Humans; *Celiac Disease/genetics/immunology/pathology; *Mutation/genetics; *T-Lymphocytes/pathology/immunology; Clone Cells; *Lymphoma/genetics/pathology; Male; Female; Adult; Middle Aged; CD3 Complex/metabolism
Research Division(s)
Immunology
PubMed ID
40367192
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-05-29 02:03:25
Last Modified: 2025-05-29 02:08:05
An error has occurred. This application may no longer respond until reloaded. Reload 🗙